文献速递产科母胎医学

孕前糖尿病与早产儿不良新生儿结局相关

Adverse neonatal outcomes associated with pregestational diabetes mellitus in infants born preterm.
PubMed 文献 · Am J Obstet Gynecol MFM · 2020-08-15

该回顾性队列研究分析了2006至2014年德克萨斯州277,210例24-36周单胎早产儿,其中4164例母亲患孕前糖尿病。调整混杂因素后,孕前糖尿病与早产儿死亡、5分钟低Apgar评分、延长辅助通气、使用表面活性物质及NICU入住风险增加相关,且不同早产亚组风险模式有差异。

要点

  • 孕前糖尿病增加早产儿死亡、低Apgar评分、辅助通气、表面活性物质及NICU入住风险。
  • 34周前早产儿中,孕前糖尿病增加辅助通气>6小时、NICU入住及惊厥风险。
  • 34-36周晚期早产儿中,孕前糖尿病增加低Apgar评分、辅助通气、表面活性物质及NICU入住风险。

核心结论

  • 孕前糖尿病与早产儿不良新生儿结局风险升高相关。

研究设计与样本

  • 回顾性队列研究纳入2006至2014年德克萨斯州24-36周单胎早产儿,排除多发分娩、死胎、先天畸形、妊娠期糖尿病及慢性高血压者,最终分析277,210例,其中4164例母亲患孕前糖尿病。

主要发现

  • 孕前糖尿病组与非糖尿病组早产儿死亡率相似,但调整混杂变量后孕前糖尿病组婴儿死亡风险增加。
  • 孕前糖尿病与早产儿5分钟低Apgar评分、辅助通气>6小时、使用表面活性物质及NICU入住风险增加相关。
  • 胎龄<34周早产儿中,孕前糖尿病与辅助通气>6小时、NICU入住及惊厥风险增加相关。
  • 胎龄34-36周晚期早产儿中,孕前糖尿病与5分钟低Apgar评分、辅助通气>6小时、使用表面活性物质及NICU入住风险增加相关。

临床怎么用

  • 对孕前糖尿病母亲的早产儿应加强新生儿监护,关注呼吸支持、Apgar评分及NICU入住需求。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Pregestational diabetes mellitus is associated with a higher risk of adverse pregnancy outcomes. Based on the available data, it is unclear whether infants born preterm to mothers with pregestational diabetes mellitus are at a higher risk of adverse outcomes than other preterm infants. OBJECTIVE: This study aimed to quantify the neonatal complications associated with pregestational diabetes mellitus in infants born preterm. STUDY DESIGN: This was a retrospective cohort study of all nonanomalous singleton neonates born in Texas from 2006 to 2014. Analysis was limited to births between 24 and 36 weeks' gestation and excluded multiple births, stillbirths, fetal congenital anomalies, neonates born to mothers with gestational diabetes mellitus, and neonates born to mothers with chronic hypertension. Results were stratified by pregestational diabetes mellitus status. Neonatal outcomes of interest included infant death, neonatal intensive care unit admission, low 5-minute Apgar scores, assisted ventilation of >6 hours, surfactant administration, and seizures. Multivariate logistic regression analysis was performed to estimate the association between pregestational diabetes mellitus and neonatal outcomes controlling for potential confounding variables. RESULTS: After predefined exclusions, 277,210 births were analyzed, 4164 of which were to mothers with pregestational diabetes mellitus. The comparison group consisted of mothers without pregestational diabetes mellitus. The preterm infant mortality rates between the pregestational diabetic and nondiabetic groups were similar. However, after adjusting for confounding variables, there was an increased risk of infant mortality for preterm neonates born to mothers with pregestational diabetes mellitus. In infants born preterm, pregestational diabetes mellitus was associated with an increased risk of infant death, low 5-minute Apgar score, prolonged assisted ventilation, surfactant requirement, and neonatal intensive care unit admission. Neonates born before 34 weeks' gestation had an increased risk of assisted ventilation of >6 hours, neonatal intensive care unit admission, and seizure. Neonates born to mothers with pregestational diabetes mellitus in the late preterm period between 34 and 36 weeks' gestation had an increased risk of low Apgar score at 5 minutes, assisted ventilation of >6 hours, surfactant use, and neonatal intensive care unit admission. CONCLUSION: Pregestational diabetes mellitus is associated with a higher risk of adverse neonatal outcomes in infants born preterm.

来源:Am J Obstet Gynecol MFM,查看原文。版权归原作者所有。

引用

  1. Tse BC, Block B, Figueroa H, et al. Adverse neonatal outcomes associated with pregestational diabetes mellitus in infants born preterm. Am J Obstet Gynecol MFM. 2020. PMID: 33345923. doi:10.1016/j.ajogmf.2020.100213

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。